Question · asked by 0 reviews
Topical triamcinolone acetonide vs Intralesional BCG-polysaccharide nucleic acid (BCG-PSN): Adverse effects
- Population
- People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
- Intervention
- Topical triamcinolone acetonide
- Comparison
- Intralesional BCG-polysaccharide nucleic acid (BCG-PSN)
- Outcome
- Adverse effects
What each review found
Include earlier review versionsNo findings match. Try fewer words or remove a filter.
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Topical triamcinolone acetonide vs Topical tacrolimus · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently… · 1 review
- Topical triamcinolone acetonide vs Topical ciclosporin · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently… · 1 review
- Topical triamcinolone acetonide vs pimecrolimus 1% · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently… · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.